These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16911477)

  • 1. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology.
    Gilmore CP; Bö L; Owens T; Lowe J; Esiri MM; Evangelou N
    Brain Pathol; 2006 Jul; 16(3):202-8. PubMed ID: 16911477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord.
    Gilmore CP; Donaldson I; Bö L; Owens T; Lowe J; Evangelou N
    J Neurol Neurosurg Psychiatry; 2009 Feb; 80(2):182-7. PubMed ID: 18829630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal cord atrophy in multiple sclerosis caused by white matter volume loss.
    Gilmore CP; DeLuca GC; Bö L; Owens T; Lowe J; Esiri MM; Evangelou N
    Arch Neurol; 2005 Dec; 62(12):1859-62. PubMed ID: 16344343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
    Gilmore CP; Geurts JJ; Evangelou N; Bot JC; van Schijndel RA; Pouwels PJ; Barkhof F; Bö L
    Mult Scler; 2009 Feb; 15(2):180-8. PubMed ID: 18845658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
    Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis.
    Gorter RP; Nutma E; Jahrei MC; de Jonge JC; Quinlan RA; van der Valk P; van Noort JM; Baron W; Amor S
    Clin Exp Immunol; 2018 Nov; 194(2):137-152. PubMed ID: 30014472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis.
    Bö L; Geurts JJ; van der Valk P; Polman C; Barkhof F
    Arch Neurol; 2007 Jan; 64(1):76-80. PubMed ID: 17210812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
    Schlaeger R; Papinutto N; Panara V; Bevan C; Lobach IV; Bucci M; Caverzasi E; Gelfand JM; Green AJ; Jordan KM; Stern WA; von Büdingen HC; Waubant E; Zhu AH; Goodin DS; Cree BA; Hauser SL; Henry RG
    Ann Neurol; 2014 Oct; 76(4):568-80. PubMed ID: 25087920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal loss in the multiple sclerosis spinal cord revisited.
    Petrova N; Carassiti D; Altmann DR; Baker D; Schmierer K
    Brain Pathol; 2018 May; 28(3):334-348. PubMed ID: 28401686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calreticulin and other components of endoplasmic reticulum stress in rat and human inflammatory demyelination.
    Ní Fhlathartaigh M; McMahon J; Reynolds R; Connolly D; Higgins E; Counihan T; Fitzgerald U
    Acta Neuropathol Commun; 2013 Jul; 1():37. PubMed ID: 24252779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
    Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
    Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically feasible MTR is sensitive to cortical demyelination in MS.
    Chen JT; Easley K; Schneider C; Nakamura K; Kidd GJ; Chang A; Staugaitis SM; Fox RJ; Fisher E; Arnold DL; Trapp BD
    Neurology; 2013 Jan; 80(3):246-52. PubMed ID: 23269598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury.
    Guest JD; Hiester ED; Bunge RP
    Exp Neurol; 2005 Apr; 192(2):384-93. PubMed ID: 15755556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord neuronal pathology in multiple sclerosis.
    Gilmore CP; DeLuca GC; Bö L; Owens T; Lowe J; Esiri MM; Evangelou N
    Brain Pathol; 2009 Oct; 19(4):642-9. PubMed ID: 19170682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
    DeLuca GC; Alterman R; Martin JL; Mittal A; Blundell S; Bird S; Beale H; Hong LS; Esiri MM
    Brain; 2013 Apr; 136(Pt 4):1025-34. PubMed ID: 23485854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions.
    Laman JD; Visser L; Maassen CB; de Groot CJ; de Jong LA; 't Hart BA; van Meurs M; Schellekens MM
    J Neuroimmunol; 2001 Sep; 119(1):124-30. PubMed ID: 11525809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Reported Spinal Cord Lesions in Progressive Multiple Sclerosis with Theiler's Murine Encephalomyelitis Virus Induced Demyelinating Disease.
    Leitzen E; Jin W; Herder V; Beineke A; Elmarabet SA; Baumgärtner W; Hansmann F
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demyelination in spinal cord injury and multiple sclerosis: what can we do to enhance functional recovery?
    Waxman SG
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S105-17. PubMed ID: 1588601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
    Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
    Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.